Final Results
The Core Business
("Core" or the "Company")
Final Results for the year to 31 May 2009
26 February 2010
The Core Business floated on AIM in March 2006 and as part of a "buy and build"
strategy completed the acquisition of Amirose International Ltd in July 2007.
Both companies operated in the beauty and personal care sectors and market and
sold brands into high street retailers, independent pharmacy, and beauty salons.
The Group's portfolio of brands included those that are wholly owned or those
that are sourced from overseas brand owners who grant the group an exclusive UK
distribution agreement to market and sell their products. The Group has no
manufacturing facilities and imports all its products from manufacturers in the
Far East and from brand owners in Australia and Europe
The Group launched its first wholly owned brand - Grace Your Face - in August
2008 in 700 Superdrug stores. In addition the Group launched the Bloom range of
colour cosmetics, having previously secured an exclusive UK distribution
agreement, into 100 Superdrug stores in October 2008.
The Group's trading pattern during the financial year suffered from a high
degree of volatility as it retailers destocked and consumer demand became
unpredictable because of the impact of the recession. The decline in the value
of Sterling also had a detrimental impact on the Group's gross margins.
The Group operated in a highly competitive and saturated market. In an effort to
provide visibility and an in-store presence for its brands the Group invested
16% of its sales value on marketing versus 13% the prior year. A large
proportion of its marketing budget was invested in supporting the Elite Models
colour cosmetics brand which had launched in 200 Superdrug stores in September
2007. Because of a lack of new product development from the brand principal,
Accesoires Beaute Cosmetiques, the Group had to promote the brand with price off
activity which led to a significant erosion of margin. In addition Elite Models
colour cosmetics suffered from poor retail sales and as a consequence low re-
order values despite the investment in marketing activity.
Grace Your Face also received considerable investment from the Group on its
launch but without a commensurate payback in high order values.
In September 2009 the directors requested the suspension of dealings in the
existing ordinary Shares on AIM when the directors became aware that trading
levels had decreased to a significant extent, as a result of which the Group's
liabilities exceeded its assets.
Amirose International Limited was placed in a creditors' voluntary liquidation
on 25 January 2010 and the net cost of the investment has been fully provided
against in the following financial statements.
The Board has been approached by Alfred Henry Corporate Finance, together with
Trafalgar Capital Specialised Investment Fund, the Company's largest secured
creditor, with proposals under which the Company is to be used as an investing
company quoted on AIM and the creditors are to be offered new ordinary shares in
satisfaction of amounts owed to them by the Company in order to eliminate the
Company's indebtedness and liabilities and provide it with the requisite
solvency to conduct a company voluntary arrangement ("CVA"), to seek a return to
trading on AIM and to fund the associated working capital requirements. The
objective would be to enable creditors and shareholders to recover some value by
holding shares in an AIM quoted investing company. Full details of the CVA are
contained in circulars that can be located on the Company's website, together
with a full copy of the Company's annual report and accounts for the year ended
31 May 2009. The annual report and accounts have been posted to shareholders today.
For further information, please contact:
The Core Business PLC www.thecorebusiness.co.uk
Stirling Murray, Chief Executive 020 8559 8244
Blomfield Corporate Finance Ltd (Nomad)
Nick Harriss 020 7444 0800
Antony Batty & Company LLP (CVA Nominee)
Antony Batty 020 7831 1234
Income Statement for the year
ended 31 May 2009
2009 2008
£ £
Revenue 1,501,170 1,345,930
Cost of sales 730,394 548,414
Gross profit 770,776 797,516
Sales and marketing (232,964) (171,547)
Administration costs (854,401) (1,151,464)
Operating loss (316,589) (525,495)
Analysed as:
Operating loss before exceptional items
Exceptional items (2,075,536) -
Operating loss after exceptional items (2,392,125) (525,495)
Financial income 277 4,755
Financial expense (68,970) (61,312)
Loss before tax (2,460,818) (582,052)
Income tax credit/(expense) - -
Loss for the year (2,460,818) (582,052)
Loss per share
Basic and diluted (0.98 p) (0.34 p)
Basic and diluted (0.15 p) (0.34 p)
(prior to exceptional Items)
Balance Sheet as at 31 May 2009
2009 2008
£ £
Assets
Non-current assets
Property, plant and equipment 155,730 86,850
Investment in subsidiary - 3,168,901
155,730 3,255,751
Current assets
Inventories - 41,269
Trade and other receivables 47,175 77,630
Cash and cash equivalents 939 3,045
48,114 121,944
Total assets 203,844 3,377,695
Equity and liabilities
Equity attributable to the Company's equity holders
Share capital 1,267,412 1,017,412
Equity reserve - 10,722
Share premium 1,182,681 1,096,431
Retained earnings (3,188,727) (727,909)
(738,634) 1,396,656
Current liabilities
Trade and other payables 313,428 329,238
Borrowings 629,050 762,713
Current tax liabilities - -
Amounts owed to group undertakings - 889,088
Total liabilities 942,478 1,981,039
Total equity and liabilities 203,844 3,377,695
Cash flow statement for the year ended 31May 2009
2009 2008
£ £
Cash flows from operating activities
Cash (used in)/generated from operations (108,279) 189,675
Interest paid (70,934) (64,996)
Tax paid - -
Net cash used in operating activities (179,213) 124,679
Cash flows from investing activities
Acquisition of subsidiary
net of cash acquired - (3,168,901)
Increase in amounts owed to
subsidiary undertaking - 889,089
Purchases of property,
plant and equipment (159,420)(110,860)
Investment in financial asset - -
Interest received 277 4,755
Net cash used in investing activities (159,143) (2,385,917)
Cash flows from financing activities
Net proceeds on issues of shares 336,250 1,411,273
Proceeds on issue of loan notes - 850,000
Increase/(decrease) in loan notes - (76,566)
Net cash from financing activities 336,250 2,184,707
Net (decrease)/ increase in
cash and cash equivalents (2,106) (76,531)
Cash and cash equivalents
at beginning of year 3,045 79,576
Cash and cash equivalents at end of year 939 3,045